News for All
[ad_1]
The timing of the agency’s expected action on the donanemab drug would be postponed beyond the first quarter, the company said.
[ad_2]
#Eli #Lilly #Alzheimer039s #Drug #Delayed #FDA #Plans #Advisory #Panel #Meeting
[ad_1] The Chinese EV maker is seeing vehicles pile up overseas amid weak demand, quality-control issues and internal tension. [ad_2]…
[ad_1] The transition comes as the company navigates waves of claims related to so-called forever chemicals that have weighed on…
[ad_1] If you buy something through our links, we may earn money from our affiliate partners. Learn more. Visual communication…
